AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions

AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions

Introduction: Cervical dystonia (CD) is a neurologic movement disorder with potentially disabling effects and significant impact on quality of life of those affected. AbobotulinumtoxinA (aboBoNT-A) was initially approved for a dilution of 500 U/1 mL and subsequently for a dilution of 500 U/2 mL, pro...

Full description

Saved in:
Bibliographic Details
Main Authors: Mark F. Lew, Robert A. Hauser, Stuart H. Isaacson, Daniel Truong, Atul T. Patel, Allison Brashear, William Ondo, Pascal Maisonobe, Khashayar Dashtipour, Laxman Bahroo, Stefan Wietek
Format: article
Language:EN
Published: Elsevier 2021
Subjects:
AbobotulinumtoxinA
Cervical dystonia
Dosing flexibility
Dilution
Treatment
Neurology. Diseases of the nervous system
RC346-429
Online Access:https://doaj.org/article/1b10f3346552463da42e87acfb171361
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doaj.org/article/1b10f3346552463da42e87acfb171361

Similar Items